Tagged With PBMs

Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups


Congress grilled little-known middlemen over the high cost of prescription drugs. Here's how they defended themselves.


These powerful but little-known companies that have been blamed for high drug prices are now coming out of the shadows for a congressional interrogation



The CEO of a $210 billion pharma company says that US drug prices are working against patients. One chart explains why.


The CEO of Merck has an ominous warning for the middlemen who stand between drug makers and patients


CARL ICAHN: The $67 billion Cigna-Express Scripts merger may 'rival the worst acquisitions in corporate history'



How a city in Illinois decided to sue to combat high drug prices after realising it was spending $500,000 on one drug


'There's other s--- in the vial': Bombshell lawsuit claims no one knows exactly what's in a drug that's cost the US government over $1 billion


What CVS is doing to mum-and-pop pharmacies in the US will make your blood boil


The biggest healthcare mergers of the year shouldn't happen -- period


Cigna is buying massive pharma middleman Express Scripts for $67 billion in a move that changes the industry as we know it


The Feds just asked a huge healthcare company who their real clients are and the answer is totally unsatisfying



The Wall Street analysts who called CVS's huge potential deal last month explain why it could 'realign' the entire industry


Amazon is making noise in pharma these days -- here's what it could all mean


A startling lawsuit against CVS could blow up what you thought you knew about drug prices


Nevada just passed one of the strictest drug pricing transparency laws in the country



States are starting to stand up to 'the new Big Tobacco' because Washington won't


One of pharma's biggest middlemen just lost a big customer --  and it exposes how the industry works


A new bill could 'lift the veil of secrecy about prescription drug prices'


The healthcare industry is starting to turn on itself as pressure over drug prices heats up